Cisplatin-based chemotherapy is the basis for the treatment of several tumor types, including testicular germ cell tumors (TGCT), ovarian cancer and lung cancer. In these cases, acquired resistance to...
Read moreIDIBELL and the Temporing Group Company, headquartered in Barcelona, have reached a sponsorship agreement to boost funding for research on amyotrophic lateral sclerosis (ALS). Temporing is one of the ...
Read moreThe research deals with functional studies of genes linked to a type of inherited blindness in order to identify potential therapeutic targets
Read moreYesterday September 20th, Ms. Magda Martí was officially presented as the new Managing Director of IDIBELL to all administration and service staff. Martin joined IDIBELL last September 12th replacing...
Read moreIDIBELL and Ferrer have developed EPICUP in order to help diagnose primary tumor and therefore to the oncologist doctor can establish the most appropriate treatment regimen for each case
Read moreThe Spanish Association against Cancer in Catalonia funs with one hundred thousand Euros five projects of Catalan emerging groups in cancer research. Two of these grants will fund two projects of IDIB...
Read moreIt is a recognition of the commitment of the institution to develop a strategy for human resources for researchers, in line with the principles of the European Charter for Researchers and the Code of ...
Read more